10.1007/bf01027775 252 TroeljK
(Portugal), 2026 Nuovi farmaci per il diabete e l'obesit: AIFA guide to responsible use, Wegovy class C classification Agenzia Italiana del Farmaco (AIFA), 2026 Mounjaro (tirzepatide): European Public Assessment Report overview European Medicines Agency, 2026 Saxenda (liraglutide): European Public Assessment Report overview European Medicines Agency, 2026 Saxenda 6 mg/mL solution for injection: Summary of Product Characteristics electronic medicines compendium (emc), 2026 Xenical (orlistat): European Public Assessment Report overview European Medicines Agency, 2026 Reviewed by Hi-Doctor's medical team Last reviewed 2026-07-27 Next review due 2027-07-27 This page is educational information about a medicine, not a recommendation to take it and not a substitute for a medical consultation
Due to the progressive loss of acinar cells and fibrosis that follows, lipase secretion is reduced in those with chronic pancreatitis
Sufferers are usually frustrated and feel abandoned by their physicians
When to Speak to Your GP About Taste Changes on GLP-1 Therapy Whilst mild taste alterations are sometimes reported with GLP-1 therapy and often manageable, certain situations warrant medical review